John P. Brancaccio, Director at Trovagene, Inc. (TROV), bought 10,000 shares at $0.80 ($8K) on 2018-06-08, disclosed to the SEC on 2018-06-13.
Open-market purchase of $8k TROV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| HEPA | BUY | 2020-12-02 | $11K | — | Filing → |
| CRDF | BUY | 2020-05-18 | $10K | — | Filing → |
| SGYP | BUY | 2017-05-30 | $23K | — | Filing → |